ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESM..................JDIM360 Ver 2.15 (14 Jul 2008) - 1999001/02394636CORRECTED EUROPEAN PATENT APPLICATIONA8A120120118W172deBibliographieenBibliographyfrBibliographieEP10164362.520100528enenen201201182012032011121420115020120118201203A61K 9/00 20060101AFI20100830BHEP A61K 47/14 20060101ALI20100830BHEP deVerfahren zur Behandlung von Netzhauterkrankungen mit einer intraokularen TamponadeenMethod for treating retinal conditions using an intraocular tamponadefrProcédé de traitement de conditions de la rétine en utilisant une tamponnade intraoculaireNovagali Pharma S.A.100189426CDM-11/EP-8760Bâtiment Genavenir IV 1, rue Pierre Fontaine91000 EvryFRGarrique, Jean-Sébastien8 voix de l'Aulne91370 Verrières le BuissonFRLallemand, Frédéric4 promenade de Barrage94260 FresnesFRHeier, Jeffrey50 Staniford Street, Ste 600Boston MA 02114USIcosa10121833783 avenue Denfert-Rochereau75014 ParisFRALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTROSESISKSMTRBAMERS

Composition comprising at least one fatty acid glycerol ester for use in or after a vitrectomy procedure, said composition being bioresorbable, being injectable in the vitreous cavity, having a density below 1, more preferably comprised between 0.90 and 1, or a density above 1 more preferably between 1 and 1.5; having a surface tension of less than 50 dynes/cm more preferably ranging from 20 and 30 dynes/cm, being not susceptible to emulsify into droplets when injected; method for treating a retinal disorder involving the use of said composition.